Atlas Trials

Administration of Fibrinogen Concentrate for Refractory Bleeding

Clinical trial NCT05091684 · TERMINATED

Trial details

NCT number
NCT05091684
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematological PatientsBleedingPlatelet Refractoriness
Start date
2022-02-10
Primary completion
2023-05-25
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.